| Literature DB >> 35028568 |
Li-Zhen Chen1, Avram J Holmes2, Xi-Nian Zuo1, Qi Dong1.
Abstract
Mental disorders are common health concerns and contribute to a heavy global burden on our modern society. It is challenging to identify and treat them timely. Neuroimaging evidence suggests the incidence of various psychiatric and behavioral disorders is closely related to the atypical development of brain structure and function. The identification and understanding of atypical brain development provide chances for clinicians to detect mental disorders earlier, perhaps even prior to onset, and treat them more precisely. An invaluable and necessary method in identifying and monitoring atypical brain development are growth charts of typically developing individuals in the population. The brain growth charts can offer a series of standard references on typical neurodevelopment, representing an important resource for the scientific and medical communities. In the present paper, we review the relationship between mental disorders and atypical brain development from a perspective of normative brain development by surveying the recent progress in the development of brain growth charts, including four aspects on growth chart utility: 1) cohorts, 2) measures, 3) mechanisms, and 4) clinical translations. In doing so, we seek to clarify the challenges and opportunities in charting brain growth, and to promote the application of brain growth charts in clinical practice.Entities:
Keywords: development; growth chart; mental health; neuroimaging; reliability
Year: 2021 PMID: 35028568 PMCID: PMC8739332 DOI: 10.1093/psyrad/kkab022
Source DB: PubMed Journal: Psychoradiology ISSN: 2634-4416
Figure 1:Brain growth charts and utilities. Key components of building a growth chart are illustrated as circles around a growth chart on brain volume. The four components (measure, cohort, mechanism, and translation) are seamlessly integrated into a growth chart model. A cohort is built to characterize individual differences in brain development across a certain age range (e.g. the school age). The cohort must include large enough and representative samples using reliable measures of the brain to achieve a valid growth chart. This chart can serve as a fundamental resource for mechanism discovery of brain development as well as its translations into clinical and educational conditions. A growth chart is also a ‘road to health’. The centered brain growth chart is developed based on the Chinese Color Nest Project cohort (Liu et al., 2021), consisting of a series of seven centile curves (98%, 90%, 75%, 50%, 25%, 10%, 2%) of brain volume for Chinese Han girls from childhood to adolescence (5–18 years old). Individual brain volume measurements can be expressed as centiles by plotting them on the chart. An individual centile indicates her brain volume, and the distance she has traveled along the growth road up to that age. It quantifies the volume/distance in terms of the centile (low versus high). The rate at which a girl grows is termed velocity and can be expressed either in measurement units (e.g. ml/year) for brain volume velocity, or alternatively in terms of centile change over time. The first form is the slope of the individual's growth curve on the chart, while, for the second, a growth curve that tracks along the centiles over time corresponds to average velocity, while if the curve crosses centiles up or down the individual is growing faster or slower than average. More details of the development of growth references and growth charts can be found in (Cole, 2012).
A non-exhaustive summary of typical brain development cohorts from prenatal to young adults.
| Longitudinal | Starting Age | Follow-up Duration | Country | Website and/or References |
|---|---|---|---|---|
| Generation R | Prenatal | From 2002* | Netherlands |
|
| GUSTO | Prenatal | From 2009* | Singapore |
|
| FinnBrain | Prenatal | From 2010* | Finland |
|
| HBCD | Prenatal | 10 years | USA |
|
| YOUth-B&C | Prenatal | 6 years | Netherlands |
|
| DCHS | Prenatal | 5 years | South Africa |
|
| CBD | 6–12 years | 1 year | China | (Fan |
| devCCNP | 6–18 years | 2.5 years | China |
|
| cVEDA | 6–23 years | 1 or 2 years | India |
|
| YOUth-C&A | 8–10 years | 6 years | Netherlands |
|
| ABCD | 9–10 years | 10 years | USA |
|
| Dev-CoG | 9–14 years | 3 years | USA |
|
| NCANDA | 12–21 years | 3 years | USA |
|
| IMAGEN | 14 years | From 2010* | UK Germany France Ireland | |
| Cross-Sectional | Age Range | Subject N | Country | Website and/or References |
| PING | 3–20 years | 1493 | USA | (Jernigan |
| HBN | 5–21 years | 10 000 | USA |
|
| NKI-RS | 6–85 years | > 1000 | USA |
|
| PNC | 8–21 years | 1445 | USA |
|
| Mixed | Age Range | Subject N | Country | Website and/or References |
| BCP | 0–5 years | ∼ 500 | USA |
|
| NIH Pediatric | 0–18 years | ∼ 500 | USA | (Evans, |
| HCP-D | 5–21 years | > 1300 | USA UK |
|
Note. The design classification is only applicable to neuroimaging measurements. Accelerated longitudinal cohorts are classified as longitudinal cohorts, and all mixed cohorts have clear cross-sectional and longitudinal portions. Asterisk indicates that this is an ongoing cohort, and how long the follow-up would last is not clear.